Glenmark Life Sciences, is a subsidiary of Nirma Limited, a diversified conglomerate with interest in consumer products, cement, chemicals and pharmaceuticals. It is a leading developer and manufacturer of select, high-value, non-commoditized, active pharmaceutical ingredients (APIs) in chronic therapeutic areas.

Starting as the API business unit of Glenmark Pharmaceuticals in 2001, the company has grown from a single manufacturing facility driven by one captive business to an independently run, professionally managed API company that is focused on providing pharma customers across markets with sustainable API solutions.

Glenmark Life Sciences has a commitment to high standards of quality and compliance and promotes a culture that nurtures innovation and out-of-the box responses to challenges of science and business.